Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anybody hearing anything from our new company, or whether we even have a new company yet?
Parents, thanks for the clarification. I agree that it is all great news. I was just hoping for a formal presentation.
Parents, I also thought this meant a full presentation, but when I look at the final program for the meeting all I see is a poster session. Please let us know if you find out about a presentation.
This is where I found the final program for the ASM general meeting: http://www.asm.org/images/asm2012_finalprogram_webv.pdf
NanoLogix Announces Development of Multi-Well, Rapid Diagnostic Test Variant and Exhibits at the American Society for Microbiology General Meeting in San Francisco
New PR: http://www.prnewswire.com/news-releases/nanologix-announces-development-of-multi-well-rapid-diagnostic-test-variant-and-exhibits-at-the-american-society-for-microbiology-general-meeting-in-san-francisco-158808395.html
Excerpt:
HUBBARD, Ohio, June 13, 2012 /PRNewswire/ -- NanoLogix (OTC Markets:NNLX) announced today its R&D team in collaboration with University of Texas Health Science Center - Houston (UTHSC-Houston) researchers, are developing a multi-well, microplate reader variant of the company's BioNanoFilter (BNF) diagnostics for use in large volume laboratory environments. Early analysis of the multi-well plates shows exceptionally fast live-threat results similar to the company's standard BNF technology. Starting this week, the NanoLogix BNF and BioNanoPore (BNP) technology will be on exhibit at booth #841 at the 112th General Meeting of the American Society for Microbiology in San Francisco, June 16 – June 19.
Research using NanoLogix technology from a recently completed clinical study will also be presented at the ASM General Meeting on June 17th. Dr. Jonathan Faro of UTHSC-Houston will present the research, which focused on detection, identification, and determination of antibiotic sensitivity of Group B Streptococcus (GBS) during pregnancy. Data showed NanoLogix diagnostics consistently provided results in a 4 to 6 hour window, dramatically shorter than standard culturing times of 48 to 72 hours. The data and the associated clinical study narrative is currently being formatted for submission for peer-review publication, as well as to the US FDA for acceptance as a non-invasive diagnostic technology.
"These are exciting times for NanoLogix," said CEO Bret Barnhizer. "Our technology has the potential to dramatically affect the course of human health and events over the past eight months have greatly enhanced our position for the future."
Rapid Live-Threat Tuberculosis Results
Recent R&D operations have also converged to dramatically enrich NanoLogix' bacteria and protozoa detection technology portfolio.
The detection for Tuberculosis (TB) utilizing NanoLogix' BNF and BioNanoPore (BNP) technologies has recently been completed by a major independent, third-party research laboratory. Live-threat TB was detected with NanoLogix BNP technology in 4 to 5 days, as opposed to 21 to 84 days with standard culture. TB was also detected and identified with the company's BNF technology in less than two hours. Peer-reviewed publication and FDA submittal are in process for results from both BNP and BNF Tuberculosis research.
"We are thrilled to be dramatically cutting bacterial detection times from days to hours for many pathogens," said Barnhizer. "Specifically, we have reduced wait times for TB from weeks to days, while protozoa detection times for Cryptosporidium, which is responsible for over 50 percent of waterborne illnesses, have been cut from weeks to hours. At the same time, we have been able to accomplish these results with improved quality of detection."
Wasn't that comment referring to the addition of aptamers, and their dramatic impact on the time required for detection?
It seems incomprehensible that the members of The Stop TB Partnership are unaware of our 1.5 hour cheap test for TB. I just can't figure out when they will acknowledge it. It certainly can't hurt to have all those people in our camp when we try to get speedy FDA approval.
Since Batelle, The Bill and Malinda Gates Foundation, NanoLogix, et al are members of The Stop TB Partnership, Could March 24th (World TB Day) be an auspicious time for a broad coverage PR about our latest TB results? Aren't we quick? Aren't we cheap?
See the poster:
http://www.stoptb.org/events/world_tb_day/2012/assets/posters/lo/WTBD2012_Poster1_LR.pdf
Check updated "Test Results" page. TB now 1.5Hours!!! Plus some others like Salmonella.
https://www.nanologix.com/test_results.html
Cryptosporidium is probably not it since it is a protozoan, not a bacterium. Methicillin-resistant Staphylococcus aureus (MRSA) would be one I would think have a big impact on hospitals in particular.
Negotiations may be complete by end of February . . .
This article indicates negotiations may not be concluded until late February---see third from last paragraph.
http://translate.google.com/translate?hl=en&sl=cs&u=http://byznys.ihned.cz/zpravodajstvi-cesko/c1-54558800-jihlavan-airplanes-sazi-po-americe-na-cinu&ei=CscnT9PdJ8aU2AXP8di7Ag&sa=X&oi=translate&ct=result&resnum=1&ved=0CD8Q7gEwAA&prev=/search%3Fq%3Dgroen%2Bskyleader%26hl%3Den%26safe%3Doff%26sa%3DX%26tbo%3D1%26biw%3D1660%26bih%3D845%26tbs%3Dqdr:w%26prmd%3Dimvns
New articles indicate, possibly, an initial order for 1,000 aircraft from China. The translations are shaky, and not a little humorous, but they do make for interesting reading. The previous articles suggested a January contract signing, so maybe we'll hear something soon.
http://translate.google.com/translate?hl=en&sl=cs&u=http://web.volny.cz/volny-cas/hi-tech-a-veda/clanek/~volny/IDC/191250/Zvolte%2520titul&ei=N7UST5yVOoShtwevnY38AQ&sa=X&oi=translate&ct=result&resnum=2&ved=0CE4Q7gEwAQ&prev=/search%3Fq%3Dgroen%2Bskyleader%26hl%3Den%26safe%3Doff%26sa%3DX%26tbo%3D1%26biw%3D1544%26bih%3D845%26tbs%3Dqdr:w%26prmd%3Dimvns
http://translate.googleusercontent.com/translate_c?hl=en&prev=/search%3Fq%3Dgroen%2Bskyleader%26hl%3Den%26safe%3Doff%26sa%3DX%26tbo%3D1%26biw%3D1544%26bih%3D845%26tbs%3Dqdr:w%26prmd%3Dimvns&rurl=translate.google.com&sl=cs&u=http://byznys.ihned.cz/c1-54176510-v-cesku-se-bude-vyrabet-nove-letadlo-pred-podpisem-je-rekordni-kontrakt-s-cinou-a-usa&usg=ALkJrhh7ucNzw61GRNzWaaKIhKvIq_qAsQ
Here is an additional article, but it seems to be merged with the SparrowHawk JV. Probably because none of the news outlets has the real story yet.
http://www.avionics-intelligence.com/news/2011/12/1561885974/jihlavan-airplanes-to-take-part-in-production-of-new-plane-press-adds-comment-by-jihlavan-airplane.html
Just doing my normal DD googling for Suntrans and Groen this morning turned up the following interesting reading:
http://translate.google.com/translate?sl=cs&tl=en&js=n&prev=_t&hl=en&ie=UTF-8&layout=2&eotf=1&u=http%3A%2F%2Fjihlava.idnes.cz%2Fv-jihlave-by-se-mohla-zacit-vyrabet-unikatni-hybridni-letadla-pt3-%2Fjihlava-zpravy.aspx%3Fc%3DA111214_1701255_jihlava-zpravy_bor&act=url
The original page is:
http://jihlava.idnes.cz/v-jihlave-by-se-mohla-zacit-vyrabet-unikatni-hybridni-letadla-pt3-/jihlava-zpravy.aspx?c=A111214_1701255_jihlava-zpravy_bor
The fourth paragraph certainly got my attention.
"Negotiations apparently are not yet over, but apparently a contract before signing. The Krížka could be closed in January." certainly got my attention.
This is really good news. I hope we are updated when the applications are submitted.
Here's a new article in the Vindicator:
http://www.vindy.com/news/2011/dec/04/pu...
Making the Shareholder meeting with FDA approval will be a close thing if we are yet to submit our application. Then, we don't know when this interview took place.
. . . To test their products with higher-level bacteria like tuberculosis or anthrax, Nanologix sends their products off to third-party labs, which Barnhizer says are excited about the results. But despite the breakthrough, it could still be months before the biotech company reaps monetary reward.
“Our sales have been minimal because we need FDA approval,” Barnhizer said. “All these studies and its raw data will be submitted to the FDA.”
After that, he believes it will take up to three months before FDA approval because of the testing’s noninvasive nature.
This is an interesting interview. David provides more insight into the Chinese JV and what will be coming out of their new factory. Be prepared to take notes.
http://www.psfradio.com/impodcast/2011/02/15/psf110215b.mp3
Don't miss the lecture David gave at the Royal Aeronautical Society
http://www.youtube.com/user/GroenAviation#p/u/4/9OxrvsRGA7c
Two great articles on TB detection that may generate some new interest:
http://www.thestreet.com/story/11294740/1/nanologix-technology-delivers-live-tuberculosis-tb-detection-results-in-a-revolutionary-4-days-versus-traditional-21-days.html
http://www.4-traders.com/news/NanoLogix-Technology-Delivers-Live-Tuberculosis-TB-Detection-Results-in-a-Revolutionary-4-Days-versu--13867723/
Thoughts please.
This is a comprehensive announcement with info on R&D activity as well as the long awaited stockholder's meeting.
http://www.sunherald.com/2011/09/06/3401880/nanologix-announces-plans-to-move.html
You're welcome. Who knows, maybe a commercial large carrier will come out before DARPA's rescue craft. If you hear when the TV show will be on, please let us know.
Thanks
Thought the group would enjoy reading the Royal Aeronautical Society's writeup for Mr. groen's lecture on the 4th of October in London. It can be found here:
http://www.aerosocietychannel.com/events/files/2011/08/Cierva-111.pdf
I don't know who or what the MMs are/is either; help us out WestTexas.
This is great exposure!
http://www.technologyreview.com/biomedicine/38404/page1/
Too far from Florida.
Unlike the past, we now have people associated with NanoLogix who are responsible for public relations. I am inclined to believe that any change in share price stemming from the release of test results, major orders, or government approvals will be more robust and take place quicker than was the case with the Battelle paper. It may be difficult to catch the wave once it starts.
The June/July issue of the Popular Rotorcraft Association's magazine is available at:
http://www.pra.org/supportfiles/ezinecontent/RC_2011_07_Jul_hires.pdf
The text of the second half of the interview with David Groen is there as well as a picture of a Hawk4 at a fly-in. Everybody that is really interested in this industry should consider joining the PRA. There's a lot of info available.
An excerpt from the interview that I thought was encouraging is:
PP: A lot of promising aviation development projects have been stalled the last few years for lack of funding. How is Groen Brothers set now going forward to pursue these goals?
DG: The joint venture provided no cash to the company and, in fact, this is not our major effort in China. It's important, and we're going to do everything we can to make that company successful with its product line. We look forward to it being so successful that it makes a lot of sense to transfer even more technology to that JV.
The things that we, including our financiers, are working on in that part of the world are big. Our hopes are high, we're alive and well, and two-and-a half years ago there wasn't much chance of that happening. There was only a handful of us who believed Groen Brothers was viable in the late summer of '08. But we are, and survived, and our prospects are better than ever.
That is consistent with phone conversations I had with their office last month. The DARPA project seems to be more related to current government financial issues than anything else. I hadn't heard about the European possibilities. What airframes are they interested in, and in what time frame?
Since I first invested in GNBA, back in the late nineties, I have been continually impressed with the company's unwavering faith in their vision for the future of aviation, and their determination to overcome whatever obstacles are put in front of them. I too am excited about the near future and am slowly adding when I can.
Thanks for your input. Please pass along any new information whenever you can, and I will do the same.
Sounds like you had some conversations while you were there. Any thing you can share?
Sorry for the bad link. This should be good:
http://www.pra.org/supportfiles/ezinecontent/RC_2011_03_Mar_hires.pdf
Popular Rotorcraft Association Magazine interview with David Groen.
http://www.pra.org/supportfiles/ezinecon...
Also listen to the podcast interview referenced at the end of page 14.
Can't take credit for this find, np61bw alerted us on the Yahoo message board.
Nice find. Thank you
That would be fantastic, but how can we find out? I couldn't even find anything that said he went to China except here on the board.
Thanks for your feedback. All the information I've gathered since the first query confirms your opinion.
I got a reply on the yahoo board:
See: http://www.linkedin.com/pub/john-tracy/11/443/797
On the Street now - Who is John Tracy?
The Street.Com now has an article referencing the Reuters interview. In it are an interesting couple of paragraphs:
/////////////
NanoLogix will return to Washington DC April 19-21, 2011 for the Food Safety Summit, where the company's technology will be on exhibit. Additional information about the event can be found at http://www.foodsafetysummit.com.
Joining NanoLogix at the Food Safety Summit will be John Tracy, who now serves the company in the position of General Operations Manager. Mr. Tracy brings 30 years of international technology management experience to NanoLogix from his career with both IBM and EMC.
//////////////////
This sounds like a positive addition, but I wonder if anyone has any more information on him. He doesn't yet appear on NNLX's management page on the website.
NTD television's (chinese) web site also has the story. There's no mention of Reuters, so maybe our PR folks out the tape together and sent it to multiple agencies.
http://english.ntdtv.com/ntdtv_en/ns_na/2011-02-16/268730158812.html
Based on the requirements for abstracts for ASM-2011 (a portion of which is shown below), one could conclude that the TMC study is complete except for the production of the final report.
To be acceptable, abstracts shall contain a concise statement of the research. Please follow a structured format, indicating in bold the four parts of your abstract:
• Background: The problem under investigation or a hypothesis;
• Methods: The experimental methods used (including numbers of microorganisms and/or patients);
• Results: The essential results obtained in summary form. Sufficient quantitative data and statistical tests must be presented to permit evaluation by reviewers (generalizations or statements such as "to be completed" are not acceptable); and,
• Conclusion: a summary of your findings which are supported by your results (statements such as "the results will be discussed" are not acceptable). Number the conclusions, if multiple ones are presented.
I found this info at:
http://gm.asm.org/index.php/scientific-program/abstracts/late-breaker-abstracts
The highlighting is my own.
Any thoughts on when that may come out?
That would be really good, but I'd still like to break even on those shares I bought in the late 90's at $2+ . . . we may need the new aircraft for that.
Okay, but after the first date, I want to go to the Prom!